I am a researcher and an entrepreneur in the science and engineering of biomedicine and healthcare. In 2022, I obtained a Ph.D. degree at the University of Queensland in Australia.
To address grand challenges in human healthcare, I am now working for the development of cutting-edge technologies and materials at bio-nano interfaces and the clinical translation of these innovations into treatments and diagnostic tools, by advancing the fundamental understanding of bio-nano interactions.
RESEARCH INTEREST:
(1) Study of biological barriers in the human body & nano-bio effects for clinical needs;
(2) Development of new materials and technologies for PK/PD improvement;
(3) Study of herbal medicines and traditional formulations for developing herb-sourced biomedical materials and glycosylation technologies;
(4) Development of omics-based approaches for pharmaceutical material development;
(5) Development of biosensing materials and technologies for POCT diagnosis and personalized medicine.
EXPERTISE:
(1) Polyphenol and polysaccharide materials for formulation and delivery of hydrophobic compounds;
(2) Immunomodulatory nanotech for cancer chemotherapy and ulcerative colitis treatment;
(3) DNA-based biosensing tech for rapid genotyping and POCT diagnosis.
I am a researcher and an entrepreneur in the science and engineering of biomedicine and healthcare. In 2022, I obtained a Ph.D. degree at the University of Queensland in Australia.
To address grand challenges in human healthcare, I am now working for the development of cutting-edge technologies and materials at bio-nano interfaces and the clinical translation of these innovations into treatments and diagnostic tools, by advancing the fundamental understanding of bio-nano interactions.
RESEARCH INTEREST:
(1) Study of biological barriers in the human body & nano-bio effects for clinical needs;
(2) Development of new materials and technologies for PK/PD improvement;
(3) Study of herbal medicines and traditional formulations for developing herb-sourced biomedical materials and glycosylation technologies;
(4) Development of omics-based approaches for pharmaceutical material development;
(5) Development of biosensing materials and technologies for POCT diagnosis and personalized medicine.
EXPERTISE:
(1) Polyphenol and polysaccharide materials for formulation and delivery of hydrophobic compounds;
(2) Immunomodulatory nanotech for cancer chemotherapy and ulcerative colitis treatment;
(3) DNA-based biosensing tech for rapid genotyping and POCT diagnosis.